Gulf Medical Proj traded at 2.27 this Friday March 13th, decreasing 0.11 or 4.62 percent since the previous trading session. Looking back, over the last four weeks, Gulf Medical Proj lost 7.58 percent. Over the last 12 months, its price rose by 11.82 percent. Looking ahead, we forecast Gulf Medical Proj to be priced at 2.35 by the end of this quarter and at 2.24 in one year, according to Trading Economics global macro models projections and analysts expectations.
Gulf Medical Projects Co PSC is a United Arab Emirates-based public shareholding company, which operates in the healthcare sector. The main activity of the Gulf Medical Projects Co PSC and its subsidiaries, together referred to as the Group, include general hospital, general clinic, import, hospital management, construction of medicine product factories, trading in medical equipment and its instruments, medicine and medical tools. The Company’s subsidiaries are: Al Zahra Pvt Hospital Dubai LLC, which operates as a general hospital and Al Zahra Neurosciences International LLC, which is engaged in investment in healthcare enterprises and development. The Company operates under the following segments: Health Services and Others, which is mainly providing health, medical care and other related services, as well as Investments, which is mainly concerned with investment properties and investment in securities.